{"ParsedSentences":["(X (X 828012125) (X |) (X GMH) (X |) (X 54142752) (X |) (X |) (X 5753062) (X |) (X 9/29/2006) (X 12:00:00) (X AM) (X |) (X Revasculization) (X of) (X occluded) (X graft) (X |) (X |) (X DIS) (X |) (X Admission) (X Date) (X :) (X 1/1/2006) (X Report) (X Status) (X :) (X Discharge) (X Date) (X :) (X 7/27/2006) (X ******) (X FINAL) (X DISCHARGE) (X ORDERS) (X ******) (X SLIKER) (X ,) (X CESAR) (X 677-87-69-8Ville) (X Synahgarl) (X Greenpu) (X Belle) (X Burg) (X ObridService) (X :) (X CARDISCHARGE) (X PATIENT) (X ON) (X :) (X 3/8/06) (X AT) (X 02:00) (X PMCONTINGENT) (X UPON) (X Attending) (X evaluationWILL) (X D/C) (X ORDER) (X BE) (X USED) (X AS) (X THE) (X D/C) (X SUMMARY) (X :) (X YESAttending) (X :) (X PIPES) (X ,) (X HORACIO) (X L.) (X ,) (X M.D.CODE) (X STATUS) (X :) (X Full) (X codeDISPOSITION) (X :) (X HomeDISCHARGE) (X MEDICATIONS) (X :) (X ACETYLCYSTEINE) (X 10) (X %) (X -LRB-) (X 100) (X MG/ML) (X -RRB-) (X 600) (X MG) (X PO) (X BID) (X X) (X 3) (X dosesStarting) (X ON) (X DAY) (X OF) (X PROCEDURE.ENTERIC) (X COATED) (X ASA) (X 325) (X MG) (X PO) (X DAILYCAPTOPRIL) (X 12.5) (X MG) (X PO) (X TIDFood/Drug) (X Interaction) (X InstructionGive) (X on) (X an) (X empty) (X stomach) (X -LRB-) (X give) (X 1hr) (X before) (X or) (X 2hr) (X afterfood) (X -RRB-) (X Override) (X Notice) (X :) (X Override) (X added) (X on) (X 11/9/06) (X byBARRIENTES) (X ,) (X JUNIOR) (X B.) (X ,) (X M.D.on) (X order) (X for) (X KCL) (X IMMEDIATE) (X RELEASE) (X PO) (X -LRB-) (X ref) (X #) (X 839932428) (X -RRB-) (X POTENTIALLY) (X SERIOUS) (X INTERACTION) (X :) (X CAPTOPRIL) (X \u0026) (X POTASSIUMCHLORIDEPOTENTIALLY) (X SERIOUS) (X INTERACTION) (X :) (X CAPTOPRIL) (X \u0026) (X POTASSIUMCHLORIDE) (X Reason) (X for) (X override) (X :) (X will) (X monitorPLAVIX) (X -LRB-) (X CLOPIDOGREL) (X -RRB-) (X 75) (X MG) (X PO) (X DAILYStarting) (X Tomorrow) (X -LRB-) (X 10/9) (X -RRB-) (X DIGOXIN) (X 0.125) (X MG) (X PO) (X DAILYCOLACE) (X -LRB-) (X DOCUSATE) (X SODIUM) (X -RRB-) (X 100) (X MG) (X PO) (X BIDLASIX) (X -LRB-) (X FUROSEMIDE) (X -RRB-) (X 40) (X MG) (X PO) (X DAILYNOVOLOG) (X -LRB-) (X INSULIN) (X ASPART) (X -RRB-) (X Sliding) (X Scale) (X -LRB-) (X subcutaneously) (X -RRB-) (X SC) (X AC) (X HOLD) (X IF) (X :) (X npoIf) (X BS) (X is) (X less) (X than) (X 125) (X ,) (X then) (X give) (X 0) (X units) (X subcutaneouslyIf) (X BS) (X is) (X 125-150) (X ,) (X then) (X give) (X 2) (X units) (X subcutaneouslyIf) (X BS) (X is) (X 151-200) (X ,) (X then) (X give) (X 3) (X units) (X subcutaneouslyIf) (X BS) (X is) (X 201-250) (X ,) (X then) (X give) (X 4) (X units) (X subcutaneouslyIf) (X BS) (X is) (X 251-300) (X ,) (X then) (X give) (X 6) (X units) (X subcutaneouslyIf) (X BS) (X is) (X 301-350) (X ,) (X then) (X give) (X 8) (X units) (X subcutaneouslyIf) (X BS) (X is) (X 351-400) (X ,) (X then) (X give) (X 10) (X units) (X subcutaneously) (X andcall) (X HO) (X Call) (X HO) (X if) (X BS) (X is) (X greater) (X than) (X 400INSULIN) (X NPH) (X HUMAN) (X 30) (X UNITS) (X SC) (X BEDTIMEInstructions) (X :) (X please) (X ck) (X FSG) (X prior) (X to) (X administrationISORDIL) (X -LRB-) (X ISOSORBIDE) (X DINITRATE) (X -RRB-) (X 20) (X MG) (X PO) (X TIDMETOPROLOL) (X TARTRATE) (X 50) (X MG) (X PO) (X BIDFood/Drug) (X Interaction) (X InstructionTake) (X consistently) (X with) (X meals) (X or) (X on) (X empty) (X stomach.NITROGLYCERIN) (X 2.5) (X MG) (X PO) (X TIDOXYCODONE) (X 5-10) (X MG) (X PO) (X Q6H) (X PRN) (X PainROSIGLITAZONE) (X 8) (X MG) (X PO) (X DAILYSENNA) (X TABLETS) (X -LRB-) (X SENNOSIDES) (X -RRB-) (X 2) (X TAB) (X PO) (X BIDZOCOR) (X -LRB-) (X SIMVASTATIN) (X -RRB-) (X 40) (X MG) (X PO) (X DAILYFood/Drug) (X Interaction) (X InstructionAvoid) (X grapefruit) (X unless) (X MD) (X instructs) (X otherwise.SPIRONOLACTONE) (X 25) (X MG) (X PO) (X DAILYFood/Drug) (X Interaction) (X Instruction) (X Give) (X with) (X mealsAlert) (X overridden) (X :) (X Override) (X added) (X on) (X 3/8/06) (X by) (X :) (X POTENTIALLY) (X SERIOUS) (X INTERACTION) (X :) (X CAPTOPRIL) (X \u0026) (X SPIRONOLACTONESERIOUS) (X INTERACTION) (X :) (X POTASSIUM) (X CHLORIDE) (X \u0026) (X SPIRONOLACTONEReason) (X for) (X override) (X :) (X Patient) (X monitored) (X as) (X outpatient) (X onthis) (X drug) (X regimenDIET) (X :) (X Patient) (X should) (X measure) (X weight) (X dailyDIET) (X :) (X House) (X /) (X Low) (X chol/low) (X sat) (X .))","(X (X fatACTIVITY) (X :) (X Walking) (X as) (X toleratedFOLLOW) (X UP) (X APPOINTMENT) (X -LRB-) (X S) (X -RRB-) (X :) (X Kenny) (X Freid) (X ,) (X MD) (X 1/21/06) (X at) (X 10am) (X scheduled) (X ,) (X Randell) (X Jebbett) (X ,) (X MD) (X after) (X completion) (X of) (X Plavix) (X ,) (X ALLERGY) (X :) (X VANCOMYCIN) (X HCLADMIT) (X DIAGNOSIS) (X :) (X CAD) (X with) (X nocturnal) (X anginaPRINCIPAL) (X DISCHARGE) (X DIAGNOSIS) (X ;) (X Responsible) (X After) (X Study) (X for) (X Causing) (X Admission) (X -RRB-) (X Revasculization) (X of) (X occluded) (X graftOTHER) (X DIAGNOSIS) (X ;) (X Conditions) (X ,) (X Infections) (X ,) (X Complications) (X ,) (X affecting) (X Treatment/StayCAD) (X s/p) (X CABG) (X 3/15) (X s/p) (X MI) (X 84) (X ,) (X 96) (X ;) (X ischemic) (X cardiomyopathy) (X EF) (X 20) (X %) (X H/o) (X non-sustained) (X VT) (X and) (X complete) (X heart) (X block) (X s/p) (X ICD) (X 2003AAA) (X s/p) (X repair) (X 2002) (X IDDM) (X PVD) (X HTN) (X Hyperlipidemia) (X Spinal) (X stenosis) (X -LRB-) (X severe) (X -RRB-) (X Chronic) (X renal) (X dysfunctionOPERATIONS) (X AND) (X PROCEDURES) (X :) (X Right) (X and) (X left) (X cardiac) (X catheterization) (X with) (X stent) (X x2) (X to) (X vein) (X graftOTHER) (X TREATMENTS/PROCEDURES) (X -LRB-) (X NOT) (X IN) (X O.R.) (X -RRB-) (X NoneBRIEF) (X RESUME) (X OF) (X HOSPITAL) (X COURSE) (X :76) (X yoM) (X with) (X CAD) (X s/p) (X CABG) (X 1997) (X presented) (X with) (X 2-3) (X weeks) (X of) (X nocturnalangina) (X with) (X increased) (X nitroglycerin) (X requirement) (X for) (X relief) (X .))","(ROOT (NP (NP (NP (NNS Givenlimitations)) (PP (IN of) (NP (NN imaging) (NNS modalities)))) (ADJP (JJ due) (PP (TO to) (NP (PRP$ his) (JJ severe) (JJ spinal) (NNS stenosis)))) (, ,) (S (S (NP (NNP MIBI/ETT)) (VP (VBD were) (RB not) (ADJP (JJ feasible)))) (, ,) (IN so) (S (NP (DT the) (NN patient)) (VP (VBD presented) (PP (IN for) (NP (NN electivecatheterization) (CD 5/16/06)))))) (. .)))","(ROOT (S (S (PP (IN Upon) (NP (NN catherization))) (, ,) (NP (CD two) (NNS occlusions)) (VP (VBD were) (VP (VBN noted) (NP (NP (NP (NNP inthe) (NNP PLV)) (: :) (NP (DT a) (ADJP (CD 90) (NN %)) (NN occlusion))) (, ,) (CONJP (RB as) (RB well) (IN as)) (NP (NP (DT a) (JJ moderate) (JJ sized) (NN plaque.Revascularization)) (SBAR (S (VP (VBD was) (VP (VBN achieved) (PP (IN with) (NP (NP (DT the) (NN placement)) (PP (IN of) (NP (JJ non-drug) (NNS alludingstents))))) (PP (TO to) (NP (DT these) (NNS lesions)))))))))))) (: ;) (S (NP (DT the) (JJ original) (ADJP (CD 90) (NN %)) (NN lesion)) (VP (VBD was) (VP (VBN stented) (PP (TO to) (NP (NP (CD 0) (NN %)) (VP (VBN occlusion))))))) (. .)))","(ROOT (S (PP (IN During) (NP (DT the) (NN catheterization))) (, ,) (NP (NNP Dr.) (NNP Taran)) (VP (VBD noted) (NP (DT a) (JJ gradient) (NN of40mmHg)) (PP (IN from) (NP (DT the) (JJ thoracic) (NN aorta))) (PP (TO to) (NP (NP (DT the) (JJ femoral) (NN aorta)) (VP (VBG raising) (NP (NP (NN thepossibility)) (PP (IN of) (NP (DT this)))) (PP (IN as) (NP (NP (DT an) (NN etiology)) (PP (IN for) (NP (NP (NNP Mr.) (NNP Mcconnell) (POS \u0027s)) (JJ severe) (ADJP (ADVP (RBR lower) (RB back)) (JJ painand)) (JJ limited) (NN ability))))) (S (VP (TO to) (VP (VB ambulate)))))))) (. .)))","(ROOT (S (NP (DT The) (NN catheterization)) (VP (VBD was) (ADJP (JJ withoutcomplications))) (. .)))","(ROOT (S (NP (DT The) (NN patient)) (VP (VP (VBD was) (VP (VBN placed) (PP (IN on) (NP (NP (NP (NNP Plavix) (NNP x)) (NP-TMP (CD 6) (NNS weeks))) (CC and) (NP (NP (NNP Aspirinindefinately)) (PP (VBG following) (NP (DT the) (NN procedure)))))))) (, ,) (CC and) (VP (VBD continued) (PP (IN on) (NP (PRP$ his) (NN home) (NN regimenof) (NNP Captopril) (, ,) (NNP Metoprolol) (, ,) (NNP Isordil) (, ,) (NNP Digoxin) (, ,) (NNP Spironalactone) (, ,) (NNP Insulin) (, ,) (NNP Lasix) (, ,) (NNP Zocor) (CC and) (NNP prn) (NNP Nitroglycerin))))) (. .)))","(ROOT (S (S (NP (NN Groin) (NNS sheaths)) (VP (VBD were) (VP (VBN removed)))) (CC and) (S (NP (NN thepatient)) (VP (VBD was) (PP (IN without) (NP (NN hematoma) (CC or) (NN bruit))))) (. .)))","(ROOT (S (S (NP (PRP He)) (VP (VP (VBD had) (NP (NP (NP (CD 2) (NNS episodes)) (PP (IN of) (NP (NP (JJ chestpressure) (JJ several) (NNS hours)) (PP (VBG following) (NP (NP (DT the) (NN procedure)) (PP (IN with) (NP (JJ negative) (NNP EKG) (NN andstable) (NNS vitals)))))))) (: ;) (NP (NP (DT the) (NNS symptoms)) (VP (VBN resolved) (PP (IN with) (NP (NN oxycodone))))))) (CC and) (VP (VBD did) (RB not) (VP (VB recur.On) (NP (NP (NN discharge)) (SBAR (S (NP (PRP he)) (VP (VBD was) (VP (VBG ambulating) (ADVP (RB confortably)) (PP (IN without) (NP (NN chest) (NN pain) (CC or) (NN shortnessof) (NN breath.ADDITIONAL) (NNS COMMENTS)))))))))))) (: :) (S (INTJ (VB Please)) (VP (VB take) (NP (PRP$ your) (NN Aspirin) (CC and) (NN Plavix)))) (. .)))","(X (X The) (X Aspirin) (X needs) (X to) (X be) (X taken) (X everyday) (X on) (X a) (X long) (X term) (X basis) (X ,) (X and) (X the) (X Plavix) (X must) (X be) (X taken) (X for) (X ATLEAST) (X 6WEEKS) (X from) (X 10/29DISCHARGE) (X CONDITION) (X :) (X StableTO) (X DO/PLAN) (X :) (X Please) (X follow) (X up) (X with) (X your) (X Cardiologist) (X ,) (X Dr.) (X GolaszewskiPlease) (X take) (X your) (X Plavix) (X 75mg) (X for) (X 6) (X weeks) (X -LRB-) (X until) (X atleast) (X 3/12/06) (X -RRB-) (X Take) (X your) (X Aspirin) (X 325mg) (X indefinatelyPlease) (X reschedule) (X appointment) (X with) (X Dr.) (X Kuick) (X to) (X receive) (X steroidinjections) (X for) (X spinal) (X stenosis) (X until) (X AFTER) (X your) (X course) (X of) (X Plavix) (X iscompleteNo) (X dictated) (X summaryENTERED) (X BY) (X :) (X YUEH) (X ,) (X EARL) (X D.) (X ,) (X M.D.) (X -LRB-) (X NQ38) (X -RRB-) (X 3/8/06) (X @) (X 11) (X ******) (X END) (X OF) (X DISCHARGE) (X ORDERS) (X ******))"]}
